The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the ...

Doctors are generally open to switching medications if you explain your concerns, especially if your current treatment isn’t effective or causes side effects. Finding the right migraine ...

Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Aaron Hart & Kelly Reynolds ...

Discover the real causes behind migraines, expert-backed treatment options, and effective strategies to prevent and manage migraine attacks.

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

Kids and teens can also get migraines, but Black and Hispanic children seen in emergency rooms are more likely to have their ...

Explore two real-life case studies where naturopathic interventions—addressing hormonal imbalances, nutritional deficiencies, ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...